Drugs
Table of Pharmacogenomic Biomarkers in Drug Labels
Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labels may contain information on genomic biomarkers and can describe:
- Drug exposure and clinical response variability
- Risk for adverse events
- Genotype-specific dosing
- Mechanisms of drug action
- Polymorphic drug target and disposition genes
The table below lists FDA-approved drugs with pharmacogenomic information in their labels. Some, but not all, of the labels include specific actions to be taken based on genetic information. Relevant sections of the label with such information are noted in the last column of the table. Biomarkers may include gene variants, functional deficiencies, expression changes, chromosomal abnormalities, and others. Microbial variants that influence sensitivity to anti-infectives are not included in the table. Please note that the table columns can be sorted.
Pharmacogenomic information can appear in different sections of the label. For more information on the relevance of information in various parts of the drug label (e.g. Indications and Usage, Dosage and Administration, Boxed Warning, etc.), please go to the relevant labeling guidance. For information on the FDA's initiative to improve prescription drug labels, visit the FDA/CDER Learn website.
Pharmacogenomic Biomarkers in Drug Labels
Drug | Therapeutic Area | Biomarker | Label Sections |
---|---|---|---|
|
Antivirals | HLA-B*5701 | Boxed Warning, Contraindications, Warnings and Precautions, Patient Counseling Information |
|
Psychiatry | CYP2D6 | Clinical Pharmacology, Dosage and Administration |
|
Oncology | PML/RARα | Boxed Warning, Clinical Pharmacology, Indications and Usage, Warnings |
|
Psychiatry | CYP2D6 | Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology |
|
Metabolic and Endocrinology | LDL receptor | Indications and Usage, Dosage and Administration, Warnings and Precautions, Clinical Pharmacology, Clinical Studies |
|
Rheumatology | TPMT | Dosage and Administration, Warnings and Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology |
|
Antivirals | IL28B | Clinical Pharmacology |
|
Oncology | CD30 | Indications and Usage, Description, Clinical Pharmacology |
|
Oncology | Ph Chromosome | Clinical Studies |
|
Oncology | DPD | Contraindications, Precautions, Patient Information |
|
Neurology | HLA-B*1502 | Boxed Warning, Warnings and Precautions |
|
Musculoskeletal | CYP2C19 | Clinical Pharmacology, Special Populations |
|
Cardiovascular | CYP2D6 | Drug Interactions, Clinical Pharmacology |
|
Analgesics | CYP2C9 | Dosage and Administration, Drug Interactions, Use in Specific Populations, Clinical Pharmacology |
|
Oncology | EGFR | Indications and Usage, Warnings and Precautions, Description, Clinical Pharmacology, Clinical Studies |
|
Oncology | KRAS | Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies |
|
Dermatology and Dental | CYP2D6 | Drug Interactions |
|
Psychiatry | CYP2D6 | Precautions |
|
Antiinfectives | G6PD | Precautions |
|
Oncology | TPMT | Clinical Pharmacology, Warnings, Precautions |
|
Psychiatry | CYP2C19 | Drug Interactions, Warnings |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Neurology | CYP2C19 | Clinical Pharmacology, Dosage and Administration, Use in Specific Populations |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Cardiovascular | CYP2C19 | Boxed Warning, Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Drug Interactions, Clinical Pharmacology |
|
Analgesics | CYP2D6 | Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology |
|
Oncology | ALK | Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies |
|
Dermatology and Dental | G6PD | Indications and Usage, Precautions, Adverse Reactions, Patient Counseling Information |
|
Oncology | Ph Chromosome | Indications and Usage, Clinical Studies, Patient Counseling Information |
|
Oncology | CD25 | Indications and Usage, Warnings and Precautions, Clinical Studies |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Gastroenterology | CYP2C19 | Clinical Pharmacology, Drug Interactions |
|
Gastroenterology | CYP1A2 | Clinical Pharmacology |
|
Neurology | CYP2D6 | Clinical Pharmacology, Warnings and Precautions |
|
Psychiatry | CYP2C19 | Drug Interactions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Precautions |
|
Reproductive | CYP2C19 | Precautions, Drug Interactions |
|
Hematology | Factor V Leiden (FV) | Warnings and Precautions |
|
Hematology | Antithrombin III deficiency (SERPINC1) | Warnings and Precautions |
|
Oncology | EGFR | Clinical Pharmacology |
|
Gastroenterology | CYP2C19 | Drug Interactions, Clinical Pharmacology |
|
Oncology | HER2/NEU | Indications and Usage, Boxed Warning, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies |
|
Oncology | ER &/ PGR | Indications and Usage, Dosage and Administration, Clinical Studies, Clinical Pharmacology |
|
Dermatology and Dental | DPD | Contraindications, Warnings |
|
Psychiatry | CYP2D6 | Warnings, Precautions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Drug Interactions, Clinical Pharmacology |
|
Rheumatology | CYP2C9 | Clinical Pharmacology, Special Populations |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Oncology | ER | Indications and Usage, Patient Counseling Information |
|
Neurology | CYP2D6 | Special Populations |
|
Oncology | EGFR | Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Clinical Pharmacology, Dosage and Administration, Drug Interactions, Specific Populations, Warnings and Precautions |
|
Oncology | C-Kit | Indications and Usage, Dosage and Administration Clinical Pharmacology, Clinical Studies |
|
Oncology | Ph Chromosome | Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies |
|
Oncology | PDGFR | Indications and Usage, Dosage and Administration, Clincal Studies |
|
Oncology | FIP1L1-PDGFRα | Indications and Usage, Dosage and Administration, Clinical Studies |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Pulmonary | UGT1A1 | Clinical Pharmacology |
|
Oncology | UGT1A1 | Dosage and Administration, Warnings, Clinical Pharmacology |
|
Cardiovascular | NAT1; NAT2 | Clinical Pharmacology |
|
Pulmonary | CFTR (G551D) | Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies |
|
Gastroenterology | CYP2C19 | Drug Interactions, Clinical Pharmacology |
|
Oncology | HER2/NEU | Indications and Usage, Clinical Pharmacology, Patient Counseling Information |
|
Hematology | Chromosome 5q | Boxed Warning, Indications and Usage, Clinical Studies, Patient Counseling |
|
Oncology | ER &/ PGR | Indications and Usage, Adverse Reactions, Clinical Studies, Clinical Pharmacology |
|
Antivirals | CCR5 | Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information |
|
Oncology | TPMT | Dosage and Administration, Contraindications, Precautions, Adverse Reactions, Clinical Pharmacology |
|
Cardiovascular | CYP2D6 | Precautions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Transplantation | HGPRT | Precautions |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Oncology | Ph Chromosome | Indications and Usage, Patient Counseling Information |
|
Oncology | UGT1A1 | Warnings and Precautions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Gastroenterology | CYP2C19 | Dosage and Administration, Warnings and Precautions, Drug Interactions |
|
Oncology | EGFR | Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies |
|
Oncology | KRAS | Indications and Usage, Clinical Pharmacology, Clinical Studies |
|
Gastroenterology | CYP2C19 | Clinical Pharmacology, Drug Interactions, Special Populations |
|
Psychiatry | CYP2D6 | Clinical Pharmacology, Drug Interactions |
|
Antivirals | IL28B | Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Clinical Pharmacology, Drug Interactions |
|
Oncology | HER2/NEU | Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies, Clinical Pharmacology |
|
Neurology | HLA-B*1502 | Warnings |
|
Psychiatry | CYP2D6 | Warnings, Precautions, Contraindications, Dosage and Administration |
|
Cardiovascular | CYP2C19 | Use in Specific Populations, Clinical Pharmacology, Clinical Studies |
|
Metabolic and Endocrinology | APOE2 | Clinical Studies, Use in Specific Populations |
|
Cardiovascular | CYP2D6 | Clinical Pharmacology |
|
Cardiovascular | CYP2D6 | Precautions, Drug Interactions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Precautions |
|
Antiarrhythmics | CYP2D6 | Precautions |
|
Gastroenterology | CYP2C19 | Drug Interactions, Clinical Pharmacology |
|
Oncology | G6PD | Boxed Warning, Contraindications |
|
Antiinfectives | NAT1; NAT2 | Adverse Reactions, Clinical Pharmacology |
|
Psychiatry | CYP2D6 | Drug Interactions, Clinical Pharmacology |
|
Gastroenterology | UCD (NAGS; CPS; ASS; OTC; ASL; ARG) | Indications and Usage, Description, Clinical Pharmacology |
|
Gastroenterology | UCD (NAGS; CPS; ASS; OTC; ASL; ARG) | Indications and Usage, Dosage and Administration, Nutritional Management |
|
Oncology | ER | Indications and Usage, Precautions, Medication Guide |
|
Oncology | Factor V Leiden (FV) | Warnings |
|
Oncology | Prothrombin mutations (F2) | Warnings |
|
Antivirals | IL28B | Clinical Pharmacology |
|
Antifungals | CYP2D6 | Drug Interactions |
|
Neurology | CYP2D6 | Dosage and Administration, Warnings, Clinical Pharmacology |
|
Oncology | TPMT | Dosage and Administration, Precautions, Warnings |
|
Psychiatry | CYP2D6 | Precautions, Warnings, Contraindications |
|
Cardiovascular | CYP2C19 | Clinical Studies |
|
Reproductive and Urologic | CYP2D6 | Clinical Pharmacology, Drug Interactions, Warnings and Precautions |
|
Oncology | CD20 antigen | Indications and Usage, Clinical Pharmacology |
|
Analgesics | CYP2D6 | Clinical Pharmacology |
|
Oncology | HER2/NEU | Indications and Usage, Precautions, Clinical Pharmacology |
|
Dermatology and Dental | PML/RARα | Boxed Warning, Dosage and Administration, Precautions |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Psychiatry | UCD (NAGS; CPS; ASS; OTC; ASL; ARG) | Contraindications, Precautions, Adverse Reactions |
|
Oncology | BRAF | Indications and Usage, Warning and Precautions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information |
|
Psychiatry | CYP2D6 | Drug Interactions |
|
Antifungals | CYP2C19 | Clinical Pharmacology, Drug Interactions |
|
Hematology | CYP2C9 | Dosage and Administration, Precautions, Clinical Pharmacology |
|
Hematology | VKORC1 | Dosage and Administration, Precautions, Clinical Pharmacology |